Wellington Management Group LLP Abbott Laboratories Transaction History

Wellington Management Group LLP

$557 Billion
Q3 2024

A detailed history of Wellington Management Group LLP transactions in Abbott Laboratories stock. As of the latest transaction made, Wellington Management Group LLP holds 25,810,977 shares of ABT stock, worth $2.95 Billion. This represents 0.53% of its overall portfolio holdings.

Number of Shares

25,810,977

Previous 25,530,536 1.1%

Holding current value

$2.95 Billion

Previous $2.65 Billion 10.93%

% of portfolio

0.53%

Previous 0.48%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $28.1 Million - $33.1 Million	280,441 Added 1.1%	25,810,977 $2.94 Billion
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $275 Million - $307 Million	-2,727,959 Reduced 9.65%	25,530,536 $2.65 Billion
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $3.09 Billion - $3.42 Billion	28,258,495 New	28,258,495 $3.21 Billion
Q4 2023 Feb 12, 2024	BUY	$90.19 - $110.4 $2.91 Billion - $3.56 Billion	32,236,101 New	32,236,101 $3.55 Billion
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $124 Million - $149 Million	1,298,219 Added 4.34%	31,208,711 $3.02 Billion
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $916 Million - $1.02 Billion	9,090,340 Added 43.66%	29,910,492 $3.26 Billion
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $582 Million - $685 Million	6,003,997 Added 40.52%	20,820,152 $2.11 Billion
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $1.25 Billion - $1.46 Billion	13,107,917 Added 767.34%	14,816,155 $1.63 Billion
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $2.41 Million - $2.79 Million	-24,899 Reduced 1.44%	1,708,238 $165 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $8.11 Million - $9.8 Million	79,466 Added 4.81%	1,733,137 $188 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $484 Million - $590 Million	-4,244,416 Reduced 71.96%	1,653,671 $196 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $877 Million - $1.07 Billion	-7,595,399 Reduced 56.29%	5,898,087 $830 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $782 Million - $865 Million	-6,700,132 Reduced 33.18%	13,493,486 $1.59 Billion
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $289 Million - $340 Million	-2,730,377 Reduced 11.91%	20,193,618 $2.34 Billion
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $899 Million - $1.06 Billion	-8,258,324 Reduced 26.48%	22,923,995 $2.75 Billion
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $401 Million - $437 Million	-3,823,064 Reduced 10.92%	31,182,319 $3.41 Billion
Q3 2020 Nov 16, 2020	SELL	$91.64 - $111.29 $84.4 Million - $103 Million	-921,527 Reduced 2.57%	35,005,383 $3.81 Billion
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $556 Million - $711 Million	-7,257,976 Reduced 16.81%	35,926,910 $3.28 Billion
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $288 Million - $421 Million	4,584,550 Added 11.88%	43,184,886 $3.41 Billion
Q4 2019 Feb 11, 2020	BUY	$78.51 - $87.4 $3.03 Billion - $3.37 Billion	38,600,336 New	38,600,336 $3.35 Billion

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account

Wellington Management Group LLP Abbott Laboratories Transaction History